Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Celularity (CELU) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Celularity (CELU) over the last 6 years, with Q3 2025 value amounting to 436.66%.

  • Celularity's EBITDA Margin fell 2634700.0% to 436.66% in Q3 2025 from the same period last year, while for Sep 2025 it was 348.6%, marking a year-over-year decrease of 2709000.0%. This contributed to the annual value of 106.78% for FY2024, which is 7546200.0% up from last year.
  • Celularity's EBITDA Margin amounted to 436.66% in Q3 2025, which was down 2634700.0% from 427.6% recorded in Q2 2025.
  • Celularity's 5-year EBITDA Margin high stood at 1266.58% for Q2 2022, and its period low was 2479.56% during Q3 2023.
  • Moreover, its 5-year median value for EBITDA Margin was 173.19% (2024), whereas its average is 591.05%.
  • Per our database at Business Quant, Celularity's EBITDA Margin soared by 31624500bps in 2022 and then crashed by -29077600bps in 2023.
  • Celularity's EBITDA Margin (Quarter) stood at 83.2% in 2021, then surged by 805bps to 586.27% in 2022, then crashed by -90bps to 59.05% in 2023, then plummeted by -3373bps to 1932.56% in 2024, then skyrocketed by 77bps to 436.66% in 2025.
  • Its EBITDA Margin was 436.66% in Q3 2025, compared to 427.6% in Q2 2025 and 172.84% in Q1 2025.